Pub. Date : 2020 Jan 1
PMID : 31585938
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PURPOSE: Lorlatinib is a third-generation ALK tyrosine kinase inhibitor with proven efficacy in patients with ALK-rearranged lung cancer previously treated with first and second-generation ALK inhibitors. | Tyrosine | ALK receptor tyrosine kinase | Homo sapiens |